EVENT
[Open Seminar] Harvey Lodish, Ph.D.
June 19, 2024
Credits: WPI-Bio2Q
Credits: WPI-Bio2Q
Credits: WPI-Bio2Q
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar as follows:
| Date & Time | Wednesday, June 12, 2024, 16:00 -17:30 |
|---|---|
| Venue | (Hybrid) 1F Lounge, Center for Integrated Medical Research, Shinanomachi Campus, Keio University and on zoom |
| Title | New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History |
| Speaker | Harvey F. Lodish, Ph.D. Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology (USA) Lead author, “Molecular Cell Biology” Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard |
| Language | English |
Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.
More Bio2Q News
【CHO School Series】Exploring the Frontiers of Life Science: A Special 3-Part Onl...
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) in collaboration with Knowledge Capital, will host a three-par...
[Publication]M cell–dependent commensal uptake confers encephalitogenic phenotyp...
Co-authored by researchers from Bio2Q and Keio University, and published in Proceedings of the National Academy of Sciences (PNAS), this stu...
【Seminar Report】WPI-Bio2Q Open Seminar
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held a seminar as follows. 17:00 -18:00 January 7, 2026 V...
[Publication]Niche-preserving transplantation promotes functional engraftment of...
Co-authored by Bio2Q and Keio University researchers, this study demonstrates a niche-preserving transplantation strategy that enables highl...
WPI-Bio2Q Newsletter "Bio2Q Connect" Vol. 2, Issue 12 Released
WPI-Bio2Q has released the latest issue of our newsletter, "Bio2Q Connect" (Vol. 2, Issue 12). This issue highlights the selection of six...

